NCT01229280View on ClinicalTrials.gov

Single Dose Bioequivalence Study of Darifenacin Tablets 7.5 mg in Fed Healthy Volunteers.

PHASE1UnknownINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

January 31, 2011

Study Completion Date

February 28, 2011

Conditions
Bioequivalency
Interventions
DRUG

Darifenacin

Single dose 7.5 mg tablets of darifenacin

DRUG

Darifenacin

Single dose 7.5 mg tablets of Darifenacin

Trial Locations (1)

11600

Center for Clinical Pharmacology Research (CCPR) Bdbeq S.A. Hospital Italiano., Montevideo

Sponsors
All Listed Sponsors
collaborator

Laboratorio Elea Phoenix S.A.

INDUSTRY

lead

Center for Clinical Pharmacology Research Bdbeq S.A.

OTHER